Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics' headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia. Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. The potential of oncolytic virotherapy is the ability to treat cancers more effectively and with minimum side-effects.

Yangshengtang Co., Ltd. engages in the management of pharmaceutical and food products. Its business activities include road cargo transportation, catering services, product packaging design, real estate development, housing rental services, business management consulting, and marketing planning services. It sells cosmetics, clothing, furniture, paper, office equipment, electronic products, communication equipment, agricultural and fishery products, and chemical products. The company was founded on March 12, 1993 and is headquartered in Hangzhou, China.

Vactech Oy engages in research and development services in the fields of preclinical vaccine development, diagnostics, and biobanking. It develops vaccine technologies for the prevention of human diseases. The firm’s products include vaccines against picornaviruses, which infect human beings and cause common cold, carditis, hepatitis, meningitis, otitis, and paralysis; and enteroviruses that cause severe illnesses. The company was founded by Heikki Antero Hyöty and Mikael Knip in 2001 and is headquartered in Tampere, Finland.

Sanofi Pasteur SA develops, manufactures, and supplies vaccines in France and internationally. The company provides vaccines for bacterial and viral diseases, including pertussis, diphtheria, typhoid fever, poliomyelitis, influenza, and mumps. It has production sites in France, the United States, Canada, China, Thailand, and Argentina. The company was formerly known as Aventis Pasteur S.A. and changed its name to Sanofi Pasteur SA in 2004. The company was founded in 1990 and is headquartered in Lyon, France. The company is headquartered in Lyon, France. Sanofi Pasteur SA operates as a subsidiary of Sanofi-Aventis.

Shenzhen Qiwang Investment Co., Ltd., established on 2007-06-18, Business scope includes general business items:investment management,Investment Advisory(No Securities,Insurance,Bank business),Information Consulting(The above does not include talent intermediaries and other restricted items),Domestic Trade(Does not contain franchise,Exclusive control,Monopoly).,The licensing program is:

Shenzhen Prekang Biotechnology Co., Ltd., established on 2009-07-16, Business scope includes general business items:Diagnostic reagents,medicine,medical instruments,Technology development of biochemical reagents;R&D and technical consultation of electronic information products;Instrumentation,Sales of glass instruments and laboratory equipment;Domestic Trade,Import and export of goods and technology.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:Genetic testing and disease screening services,Clinical Laboratory Services;Class II,Class III6840Production of in vitro diagnostic reagents(run by a branch,The medical device manufacturer license is valid until2020year8moon19day);Sales of in vitro diagnostic reagents(Except special management diagnostic reagents,The medical device business enterprise license is valid until2020year10moon28day).

Puzheng Pharmaceutical Group Co., Ltd., established on 2009-06-03, Business scope includes licensed projects:Drug retail,Drug Wholesale,Drug import and export,pharmaceutical production,Cosmetic production,Health food sales,Health food production,food production,medical service,Production of tea products,food business,liquor business,food business(Selling prepackaged food)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Chinese herbal medicine planting,Personal Hygiene Sales,Cosmetics Retail,Cosmetics Wholesale,Traditional Chinese Medicine Health Care Services(non-medical),Bio-organic fertilizer research and development,Biochemical product technology research and development,Engineering and Technology Research and Experimental Development,Standardized service,tea planting,Medical Research and Experimental Development,Chinese herbal medicine acquisition(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Shenzhen Gangzhu Medical Technology Co., Ltd., established on 2016-04-06, Business scope includes general business items:Technical development of biological products,consult,Serve;R&D and sales of Class I medical devices;Domestic Trade,Import and export of goods and technology.(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council);In vitro diagnostic reagents,Technical development and sales of experimental analysis instruments and raw materials(Does not contain pharmaceutical products and other restricted items).,The licensing program is:Production of Class I Medical Devices;In vitro diagnostic reagents,Production of experimental analysis instruments and raw materials.

Sichuan Academy of Chinese Medicine Sciences, a subsidiary of Province of Sichuan, is a company headquartered in China that manufactures medicinal chemicals.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

iNtRON Biotechnology, Inc. engages in the development of super-bacteria treatment, antibiotics alternatives, bio new drug, molecular diagnostics and artificial blood. Its products include anti-bacterial agents, identification kits, research reagents and kits. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea.

Merck Sharp & Dohme LLC, part of Merck & Co., Inc., is a company headquartered in Kenilworth, NJ, that operates as a pharmaceutical company.

Shanghai Berger Medical Technology Co., Ltd., established on 2017-03-01, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Instrument sales;Health Consulting Services(Does not include medical services);Data processing and storage support services;Conference and Exhibition Services;Auto New Car Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps, as well as animal rabies vaccine for canines. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufactured it for the Chinese Central Government, pursuant to the government-stockpiling program. The company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program. Sinovac is developing a number of new pipeline vaccines including vaccines for enterovirus 71 (against hand, foot, and mouth disease), of which the EV71 vaccine is currently in Phase III clinical trials, pneumococcal conjugate, pneumococcal polysaccharides, and rubella. Sinovac sells its vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines.